Current Research and Development of Chemotherapeutic Agents for Melanoma
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Research and Development of Chemotherapeutic Agents for Melanoma
Authors
Keywords
-
Journal
Cancers
Volume 2, Issue 2, Pages 397-419
Publisher
MDPI AG
Online
2010-04-12
DOI
10.3390/cancers2020397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma
- (2011) Minakshi Nihal et al. CELL CYCLE
- Preventive Effect of Green Tea Catechins on Experimental Tumor Metastasis in Senescence-Accelerated Mice
- (2010) Kosuke Shimizu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial
- (2010) Ewa Wierzbicka-Hainaut et al. MELANOMA RESEARCH
- Phase I/II Study of a Cisplatin-Taxol-Dacarbazine Regimen in Metastatic Melanoma
- (2009) Nicholas E. Papadopoulos et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Therapeutic potential of n-3 polyunsaturated fatty acids in disease
- (2009) J. W. Fetterman et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Small molecules and targeted therapies in distant metastatic disease
- (2009) P. Hersey et al. ANNALS OF ONCOLOGY
- Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma
- (2009) Francesco Recchia et al. ANTI-CANCER DRUGS
- Antioxidant Supplementation and Risk of Incident Melanomas
- (2009) Maryam M. Asgari et al. ARCHIVES OF DERMATOLOGY
- Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor
- (2009) Lei Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis
- (2009) S. Mocellin et al. CARCINOGENESIS
- Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma
- (2009) Patrick A. Ott et al. CHEMOTHERAPY
- A prospective study of gout and cancer
- (2009) Paolo Boffetta et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells
- (2009) Xiaoyuan Xu et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
- (2009) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients
- (2009) Laura Ridolfi et al. MELANOMA RESEARCH
- An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells
- (2009) L. Wang et al. MOLECULAR PHARMACOLOGY
- Evidence ofγ-Tocotrienol as an Apoptosis-Inducing, Invasion-Suppressing, and Chemotherapy Drug-Sensitizing Agent in Human Melanoma Cells
- (2009) Piek Ngoh Chang et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Methyl jasmonate: A plant stress hormone as an anti-cancer drug
- (2009) Sharon Cohen et al. PHYTOCHEMISTRY
- Everolimus Represents an Advance in Immunosuppression for Patients Who Have Developed Cancer After Renal Transplantation
- (2009) E. González et al. TRANSPLANTATION PROCEEDINGS
- Depigmenting Mechanisms of All-Trans Retinoic Acid and Retinol on B16 Melanoma Cells
- (2008) Kazuomi SATO et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- An enhanced apoptosis and a reduced angiogenesis are associated with the inhibition of lung colonisation in animals fed an n-3 polyunsaturated fatty acid-rich diet injected with a highly metastatic murine melanoma line
- (2008) Antonella Mannini et al. BRITISH JOURNAL OF NUTRITION
- Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma
- (2008) Domingo G. Perez et al. CANCER
- Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
- (2008) Kevin B. Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma
- (2008) Xin Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
- (2008) D. B. Solit et al. CLINICAL CANCER RESEARCH
- Therapeutic strategies for inhibiting oncogenic BRAF signaling
- (2008) Ensar Halilovic et al. CURRENT OPINION IN PHARMACOLOGY
- Mammalian target of rapamycin as a therapeutic target in oncology
- (2008) Robert T Abraham et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Anti-metastatic potential of Punarnavine, an alkaloid from Boerhaavia diffusa Linn.
- (2008) K.A. Manu et al. IMMUNOBIOLOGY
- Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro
- (2008) Xiao-yan Liu et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production
- (2008) Seung Koo Lee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Using Benchmarks Based on Historical Survival Rates for Screening New Therapies for Stage IV Melanoma Patients
- (2008) Phyllis A. Gimotty et al. JOURNAL OF CLINICAL ONCOLOGY
- Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group
- (2008) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
- (2008) Edward L. Korn et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
- (2008) Michael B. Atkins et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous Melanoma
- (2008) Victoria R. Greene et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma
- (2008) M. González-Cao et al. ONCOLOGY
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)
- (2007) Mepur H. Ravindranath et al. Evidence-based Complementary and Alternative Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now